These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34273512)

  • 1. Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.
    Yamaguchi T; Shinagawa T; Kobata H; Nakagawa H
    Int J Infect Dis; 2021 Aug; 109():261-268. PubMed ID: 34273512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
    Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
    Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
    PLoS Pathog; 2023 Jul; 19(7):e1011032. PubMed ID: 37498934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
    Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
    Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity.
    Wang J; Li D; Cameron A; Zhou Q; Wiltse A; Nayak J; Pecora ND; Zand MS
    J Infect Dis; 2022 Aug; 226(3):474-484. PubMed ID: 35091739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.
    Wratil PR; Schmacke NA; Karakoc B; Dulovic A; Junker D; Becker M; Rothbauer U; Osterman A; Spaeth PM; Ruhle A; Gapp M; Schneider S; Muenchhoff M; Hellmuth JC; Scherer C; Mayerle J; Reincke M; Behr J; Kääb S; Zwissler B; von Bergwelt-Baildon M; Eberle J; Kaderali L; Schneiderhan-Marra N; Hornung V; Keppler OT
    Cell Rep; 2021 Dec; 37(13):110169. PubMed ID: 34932974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural mapping of antibody landscapes to human betacoronavirus spike proteins.
    Bangaru S; Antanasijevic A; Kose N; Sewall LM; Jackson AM; Suryadevara N; Zhan X; Torres JL; Copps J; de la Peña AT; Crowe JE; Ward AB
    Sci Adv; 2022 May; 8(18):eabn2911. PubMed ID: 35507649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020.
    Sermet-Gaudelus I; Temmam S; Huon C; Behillil S; Gajdos V; Bigot T; Lurier T; Chrétien D; Backovic M; Delaunay-Moisan A; Donati F; Albert M; Foucaud E; Mesplées B; Benoist G; Faye A; Duval-Arnould M; Cretolle C; Charbit M; Aubart M; Auriau J; Lorrot M; Kariyawasam D; Fertitta L; Orliaguet G; Pigneur B; Bader-Meunier B; Briand C; Enouf V; Toubiana J; Guilleminot T; van der Werf S; Leruez-Ville M; Eloit M
    Euro Surveill; 2021 Apr; 26(13):. PubMed ID: 33797390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases.
    Deakin CT; Cornish GH; Ng KW; Faulkner N; Bolland W; Hope J; Rosa A; Harvey R; Hussain S; Earl C; Jebson BR; Wilkinson MGLL; Marshall LR; O'Brien K; Rosser EC; Radziszewska A; Peckham H; Patel H; Heaney J; Rickman H; Paraskevopoulou S; Houlihan CF; Spyer MJ; Gamblin SJ; McCauley J; Nastouli E; Levin M; Cherepanov P; Ciurtin C; Wedderburn LR; Kassiotis G
    Med; 2021 Sep; 2(9):1093-1109.e6. PubMed ID: 34414384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
    Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
    bioRxiv; 2022 Dec; ():. PubMed ID: 36482973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
    Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43.
    Demers-Mathieu V; DaPra C; Mathijssen GB; Medo E
    J Perinatol; 2021 May; 41(5):952-960. PubMed ID: 33649442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete IgG avidity maturation after seasonal coronavirus infections.
    Struck F; Schreiner P; Staschik E; Wochinz-Richter K; Schulz S; Soutschek E; Motz M; Bauer G
    J Med Virol; 2022 Jan; 94(1):186-196. PubMed ID: 34427932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional SARS-CoV-2 cross-reactive CD4
    Humbert M; Olofsson A; Wullimann D; Niessl J; Hodcroft EB; Cai C; Gao Y; Sohlberg E; Dyrdak R; Mikaeloff F; Neogi U; Albert J; Malmberg KJ; Lund-Johansen F; Aleman S; Björkhem-Bergman L; Jenmalm MC; Ljunggren HG; Buggert M; Karlsson AC
    Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2220320120. PubMed ID: 36917669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
    Tamminen K; Salminen M; Blazevic V
    Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.